• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌胚抗原水平与甲状腺髓样癌的晚期疾病相关。

Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.

机构信息

McGill University Health Center, Montreal, QC, Canada.

Department of Otolaryngology-Head and Neck Surgery, Sir Mortimer B. Davis-Jewish General Hospital, Montreal, Canada.

出版信息

J Otolaryngol Head Neck Surg. 2018 Sep 17;47(1):55. doi: 10.1186/s40463-018-0303-x.

DOI:10.1186/s40463-018-0303-x
PMID:30223887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6142324/
Abstract

BACKGROUND

Medullary thyroid cancer (MTC) cells are capable of secreting various tumor markers including calcitonin and carcinoembyronic antigen (CEA). The purpose of this study is to determine whether abnormal CEA levels may be used as a tumor marker to predict the severity of disease in MTC.

METHODS

A retrospective analysis was completed for 33 patients with MTC who had preoperative serum CEA levels. Univariate and multivariate analyses were used to quantify the relationship between serum CEA levels and tumor stage and prognosis.

RESULTS

On multivariate analysis, elevated preoperative CEA levels were significantly associated with the size and stage of tumor, distant metastasis, decreased biochemical cure, and mortality. There was a significant association between tumor size greater than 37 mm and elevated CEA levels (> 271 ng/ml). There was also a positive correlation with increased cancer stage (> 377 ng/ml), distant metastasis (> 405 ng/ml), and contralateral compartment location of lymph node metastasis (> 162 ng/ml). When pre-operative CEA levels are > 500 ng/ml, patient mortality was 67%.

CONCLUSION

In this study, both pre-operative calcitonin and CEA levels were significantly correlated with the extent of disease in MTC. While calcitonin has a linear relationship with disease progression, abnormal CEA levels were a better indicator of advanced disease. CEA levels > 271 ng/ml are significant for advanced tumor size and staging, metastasis to the central compartment, and decreased chance of biochemical cure. CEA levels greater than 500 ng/ml are associated with significant patient mortality.

摘要

背景

甲状腺髓样癌(MTC)细胞能够分泌各种肿瘤标志物,包括降钙素和癌胚抗原(CEA)。本研究旨在确定 CEA 水平异常是否可作为肿瘤标志物,预测 MTC 疾病的严重程度。

方法

对术前 CEA 水平升高的 33 例 MTC 患者进行回顾性分析。采用单因素和多因素分析来量化 CEA 水平与肿瘤分期和预后之间的关系。

结果

多因素分析显示,术前 CEA 水平升高与肿瘤大小和分期、远处转移、生化治愈率降低和死亡率显著相关。肿瘤大小>37mm 与 CEA 水平升高(>271ng/ml)显著相关。CEA 水平与癌症分期增加(>377ng/ml)、远处转移(>405ng/ml)和对侧淋巴结转移中央隔室位置(>162ng/ml)也呈正相关。当术前 CEA 水平>500ng/ml 时,患者死亡率为 67%。

结论

在本研究中,术前降钙素和 CEA 水平均与 MTC 疾病的严重程度显著相关。虽然降钙素与疾病进展呈线性关系,但 CEA 水平是晚期疾病的更好指标。CEA 水平>271ng/ml 与肿瘤较大、分期较高、中央隔室转移以及生化治愈率降低显著相关。CEA 水平大于 500ng/ml 与显著的患者死亡率相关。

相似文献

1
Carcinoembryonic antigen levels correlated with advanced disease in medullary thyroid cancer.癌胚抗原水平与甲状腺髓样癌的晚期疾病相关。
J Otolaryngol Head Neck Surg. 2018 Sep 17;47(1):55. doi: 10.1186/s40463-018-0303-x.
2
Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.癌胚抗原水平异常与甲状腺髓样癌进展:一项多变量分析
Arch Surg. 2007 Mar;142(3):289-93; discussion 294. doi: 10.1001/archsurg.142.3.289.
3
Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.联合检测降钙素、癌胚抗原和神经元特异性烯醇化酶预测甲状腺髓样癌的侧颈部淋巴结转移。
J Clin Lab Anal. 2020 Jul;34(7):e23278. doi: 10.1002/jcla.23278. Epub 2020 Mar 6.
4
Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.在接受初始手术治疗的甲状腺髓样癌患者中,术前基础降钙素和肿瘤分期与术后降钙素正常化相关。
Surgery. 2011 Dec;150(6):1168-77. doi: 10.1016/j.surg.2011.09.043.
5
High CEA levels in a case of resected colorectal cancer: delayed diagnosis of metachronous medullary thyroid cancer.一例结直肠癌切除术后 CEA 水平升高:继发嗜铬细胞瘤的延迟诊断。
World J Surg Oncol. 2017 Dec 29;15(1):230. doi: 10.1186/s12957-017-1303-4.
6
Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.所选生化标志物在检测甲状腺髓样癌复发中的诊断价值——降钙素、降钙素原、嗜铬粒蛋白A和癌胚抗原的比较
Endokrynol Pol. 2017;68(4):434-437. doi: 10.5603/EP.a2017.0038. Epub 2017 Jun 6.
7
Long-Term Follow-up in Medullary Thyroid Carcinoma.甲状腺髓样癌的长期随访
Recent Results Cancer Res. 2015;204:207-25. doi: 10.1007/978-3-319-22542-5_10.
8
Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.仅在存在大量甲状腺髓样癌病灶时,血清降钙素水平有轻度至中度升高。
Rev Esp Med Nucl Imagen Mol. 2015 Nov-Dec;34(6):378-82. doi: 10.1016/j.remn.2015.05.007. Epub 2015 Sep 26.
9
CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.降钙素分泌指数与甲状腺髓样癌隐匿性淋巴结疾病。
Endocr Pract. 2018 May;24(5):460-467. doi: 10.4158/EP-2017-0236.
10
Cure and survival of sporadic medullary thyroid carcinoma following systematic preoperative calcitonin screening.系统术前降钙素筛查后散发性甲状腺髓样癌的治愈和生存。
Langenbecks Arch Surg. 2019 Jun;404(4):411-419. doi: 10.1007/s00423-019-01764-3. Epub 2019 Mar 22.

引用本文的文献

1
Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies.甲状腺癌:流行病学、分类、危险因素、诊断和预后标志物以及当前的治疗策略。
Int J Mol Sci. 2025 May 28;26(11):5173. doi: 10.3390/ijms26115173.
2
Long-Term Follow-Up in Medullary Thyroid Carcinoma Patients.甲状腺髓样癌患者的长期随访
Recent Results Cancer Res. 2025;223:267-291. doi: 10.1007/978-3-031-80396-3_11.
3
Epidemiology, Clinical Presentation, and Diagnosis of Medullary Thyroid Carcinoma.甲状腺髓样癌的流行病学、临床表现及诊断

本文引用的文献

1
Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.转移性淋巴结比率可进一步对甲状腺髓样癌患者的死亡风险进行分层:一项基于人群的分析。
Oncotarget. 2016 Oct 4;7(40):65937-65945. doi: 10.18632/oncotarget.11725.
2
Calcitonin as Biomarker for the Medullary Thyroid Carcinoma.降钙素作为甲状腺髓样癌的生物标志物。
Recent Results Cancer Res. 2015;204:117-37. doi: 10.1007/978-3-319-22542-5_5.
3
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Recent Results Cancer Res. 2025;223:93-127. doi: 10.1007/978-3-031-80396-3_4.
4
Diagnosis and treatment of a rare bilateral primary thyroid cancer: a case report.罕见双侧原发性甲状腺癌的诊断与治疗:一例报告
Front Oncol. 2025 Feb 13;14:1468550. doi: 10.3389/fonc.2024.1468550. eCollection 2024.
5
Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence.使用多模态真实世界数据和可解释人工智能解码泛癌治疗结果
Nat Cancer. 2025 Feb;6(2):307-322. doi: 10.1038/s43018-024-00891-1. Epub 2025 Jan 30.
6
Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin.基于癌胚抗原和降钙素变化的甲状腺髓样癌的管理。
Front Endocrinol (Lausanne). 2024 Oct 10;15:1418657. doi: 10.3389/fendo.2024.1418657. eCollection 2024.
7
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer.术前降钙素和癌胚抗原值可能预测甲状腺髓样癌患者颈部侧方淋巴结转移范围。
Cancers (Basel). 2024 Aug 27;16(17):2979. doi: 10.3390/cancers16172979.
8
Elevated Procalcitonin Levels can Occur in Bacterial Infections and also in Medullary Thyroid Carcinoma.降钙素原水平升高可发生于细菌感染,也可发生于甲状腺髓样癌。
Eur J Case Rep Intern Med. 2024 Jun 27;11(7):004679. doi: 10.12890/2024_004679. eCollection 2024.
9
Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.Ki67 增殖指数在神经内分泌和内分泌肿瘤中的诊断、预后和预测作用:过去、现在和未来。
Endocr Pathol. 2023 Mar;34(1):79-97. doi: 10.1007/s12022-023-09755-3. Epub 2023 Feb 17.
10
Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?甲状腺髓样癌诊断与管理的最新进展:近年来有哪些变化?
Cancers (Basel). 2022 Jul 27;14(15):3643. doi: 10.3390/cancers14153643.
美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
4
False positive results using calcitonin as a screening method for medullary thyroid carcinoma.使用降钙素作为甲状腺髓样癌筛查方法时的假阳性结果。
Indian J Endocrinol Metab. 2013 May;17(3):524-8. doi: 10.4103/2230-8210.111677.
5
A high level of carcinoembryonic antigen as initial manifestation of medullary thyroid carcinoma in a patient with subclinical hyperthyroidism.
Int Surg. 2011 Jul-Sep;96(3):254-9. doi: 10.9738/cc55.1.
6
Preoperative basal calcitonin and tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thyroid carcinoma.在接受初始手术治疗的甲状腺髓样癌患者中,术前基础降钙素和肿瘤分期与术后降钙素正常化相关。
Surgery. 2011 Dec;150(6):1168-77. doi: 10.1016/j.surg.2011.09.043.
7
Biomarker-based risk stratification for previously untreated medullary thyroid cancer.基于生物标志物的未经治疗的甲状腺髓样癌风险分层。
J Clin Endocrinol Metab. 2010 Jun;95(6):2655-63. doi: 10.1210/jc.2009-2368. Epub 2010 Mar 25.
8
Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls.C细胞疾病中降钙素水平的测定:临床意义及潜在陷阱
Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):35-44. doi: 10.1038/ncpendmet1023.
9
Calcitonin measurement in the evaluation of thyroid nodules in the United States: a cost-effectiveness and decision analysis.在美国甲状腺结节评估中降钙素测量的成本效益与决策分析
J Clin Endocrinol Metab. 2008 Jun;93(6):2173-80. doi: 10.1210/jc.2007-2496. Epub 2008 Mar 25.
10
Incidental thyroid carcinoma in patients with Graves' disease.格雷夫斯病患者中的偶然甲状腺癌
Am J Surg. 2008 Mar;195(3):292-7; discussion 297. doi: 10.1016/j.amjsurg.2007.12.006.